IRIS
Gennari, Alessandra
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.604
NA - Nord America 4.452
AS - Asia 3.757
SA - Sud America 608
AF - Africa 132
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 8
Totale 14.571
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.309
RU - Federazione Russa 1.524
IT - Italia 1.085
SG - Singapore 1.079
IE - Irlanda 1.038
CN - Cina 854
VN - Vietnam 604
DE - Germania 588
HK - Hong Kong 548
BR - Brasile 434
SE - Svezia 379
UA - Ucraina 328
FR - Francia 246
BD - Bangladesh 151
GB - Regno Unito 144
IN - India 117
ID - Indonesia 100
KR - Corea 85
CA - Canada 79
AR - Argentina 67
BJ - Benin 58
FI - Finlandia 52
AT - Austria 45
NL - Olanda 42
MX - Messico 40
TR - Turchia 32
JP - Giappone 31
ES - Italia 27
IR - Iran 27
PL - Polonia 26
EC - Ecuador 25
PK - Pakistan 25
IQ - Iraq 23
LT - Lituania 21
ZA - Sudafrica 21
VE - Venezuela 19
BE - Belgio 18
CO - Colombia 16
PY - Paraguay 16
PE - Perù 13
MA - Marocco 12
CL - Cile 11
UZ - Uzbekistan 10
DZ - Algeria 9
AU - Australia 8
CZ - Repubblica Ceca 8
EG - Egitto 8
EU - Europa 8
KG - Kirghizistan 7
PH - Filippine 7
TH - Thailandia 7
NP - Nepal 6
SA - Arabia Saudita 6
ET - Etiopia 5
KE - Kenya 5
LB - Libano 5
RO - Romania 5
TN - Tunisia 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
JM - Giamaica 4
MY - Malesia 4
RS - Serbia 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
CH - Svizzera 3
HU - Ungheria 3
JO - Giordania 3
KZ - Kazakistan 3
MK - Macedonia 3
BG - Bulgaria 2
CI - Costa d'Avorio 2
GR - Grecia 2
GY - Guiana 2
HR - Croazia 2
IL - Israele 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PA - Panama 2
PT - Portogallo 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CG - Congo 1
CR - Costa Rica 1
CU - Cuba 1
DM - Dominica 1
GD - Grenada 1
GM - Gambi 1
GT - Guatemala 1
HN - Honduras 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LK - Sri Lanka 1
Totale 14.559
Salva come PNG Salva come JPEG
Città #
Dublin 1.032
Jacksonville 599
Hong Kong 544
San Jose 491
Singapore 475
Piemonte 373
Ashburn 355
Council Bluffs 272
Beijing 258
Dearborn 230
Moscow 210
Los Angeles 192
Ho Chi Minh City 159
Lauterbourg 156
Lawrence 129
Princeton 129
Wilmington 127
Dong Ket 116
Chandler 96
Hanoi 94
Seoul 77
Jakarta 76
Buffalo 75
Santa Clara 73
New York 69
Novara 64
Cotonou 58
Milan 55
Dallas 48
Bremen 47
Nuremberg 47
Redondo Beach 47
Ann Arbor 46
São Paulo 46
San Mateo 45
Munich 43
Helsinki 38
Columbus 36
Toronto 35
Falkenstein 34
Rome 33
Frankfurt am Main 32
Orem 32
Turin 32
Guangzhou 30
Tianjin 29
Amsterdam 25
London 23
Tokyo 23
Haiphong 22
Houston 22
Da Nang 21
Denver 21
Hangzhou 21
Boardman 20
Vienna 20
Atlanta 19
Montreal 19
Shanghai 19
Warsaw 19
Chennai 18
Poplar 18
Shenzhen 18
Nanjing 17
Brooklyn 16
Brussels 16
Mexico City 16
Biên Hòa 15
Phoenix 15
Rio de Janeiro 15
Andover 13
Ankara 13
Chicago 13
Hefei 13
Norwalk 13
Strasbourg 13
Turku 13
Johannesburg 12
Monmouth Junction 12
Naples 12
Reggio Emilia 12
San Francisco 12
St Louis 12
Boston 11
Baghdad 10
Bologna 10
Fairfield 10
Kunming 10
Mumbai 10
Seattle 10
Stockholm 10
Florence 9
Genoa 9
Odalengo Grande 9
Quito 9
Tashkent 9
Zanjan 9
Ardabil 8
Barnet 8
Brasília 8
Totale 8.064
Salva come PNG Salva come JPEG
Nome #
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 257
A randomized clinical study on the impact of Comprehensive Geriatric Assessment (CGA) based interventions on the quality of life of elderly, frail, onco-hematologic patients candidate to anticancer therapy: protocol of the ONCO-Aging study 233
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 200
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 181
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry 170
Metastatic mediastinal germ-cell tumor and concurrent COVID-19: when chemotherapy is not deferrable. 150
Impact of Rehabilitation on Breast Cancer Related Fatigue: A Pilot Study 144
Adjuvant pertuzumab and trastuzumab in early her2-positive breast cancer 139
Axillary web syndrome in women after breast cancer surgery referred to an Oncological Rehabilitation Unit: which are the main risk factors? A retrospective case-control study 136
Insulin-like Growth Factor-1 Receptor (IGF-1R) expression on Circulating Tumor Cells (CTCs) and metastatic breast cancer outcome: results from the TransMYME trial 135
Time-Dependent COVID-19 Mortality in Patients with Cancer: An Updated Analysis of the OnCovid Registry 134
Bone health, vitamin D status and oral hygiene screening in breast cancer women before starting osteoporosis treatment: a cross-sectional study 133
A randomized phase II study evaluating different maintenance schedules of nab-Paclitaxel in the first-line treatment of metastatic breast cancer: final results of the IBCSG 42-12/BIG 2-12 SNAP trial 132
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: The OnCovid Inflammatory Score 130
Insulin/IGF Axis in Breast Cancer: Clinical Evidence and Translational Insights 126
Efficacy and safety of antibody-drug conjugates in pretreated HER2-low metastatic breast cancer: A systematic review and network meta-analysis 124
3rd ESO-ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3). 122
Presenting features and early mortality from SARS-CoV-2 infection in cancer patients during the initial stage of the COVID-19 pandemic in Europe 122
Prevalence and impact of COVID-19 sequelae on treatment pathways and survival of patients with cancer who recovered from SARS-Cov-2 infection: results from the OnCovid registry. 121
Aging and endothelial function in normotensive subjects and patients with essential hypertension 119
3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3) 119
Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients 119
Anthracyclines in the management of metastatic breast cancer: state of the art 118
Breast Cancer Survivorship, Quality of Life and Late Toxicities 116
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry 116
Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer 115
A Simon's two-stage design trial evaluating the potential role of a kind of honey in preventing chemotherapy-hematopoietic toxicities 115
Curative Lung Metastasectomy Without Concomitant Androgen Deprivation Therapy in Oligometastatic Castration-resistant Prostate Cancer: A Case Report and Review of the Literature 115
[18F]FDG-PET/CT in adrenal lesions: diagnostic performance in different clinical settings 114
Weight Management Effectiveness and Predictors of Dropout in Breast Cancer Survivors: A Retrospective Study 113
[Management of nausea and vomiting in cancer patients. Use of transdermal patches containing granisetron in patients affected by head and neck squamous-cell carcinoma] 113
An observational study of nasal cavity toxicity in cancer patients treated with bevacizumab 112
18F-FDG PET/CT is a prognostic biomarker in patients affected by bone metastases from breast cancer in comparison with 18F-NaF PET/CT 112
HER2 overexpression as a prognostic factor in metastatic breast cancer patients treated with high-dose chemotherapy and autologous stem cell support 112
Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries 109
Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial 109
Chemotherapy of non-small-cell lung cancer: Role of erythropoietin in the management of anemia 108
Activity of first-line epirubicin and paclitaxel in metastatic breast cancer is independent of type of adjuvant therapy 107
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE). 106
Identification of a prognostic signature based on the expression of genes related to the insulin pathway in early breast cancer 104
COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry 104
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study 103
Precision Medicine in Systemic Mastocytosis 103
Anthracycline-free therapy for HER2-amplified breast cancer 102
Adjuvant chemotherapy in breast cancer. International perspective 102
ERA-Net TRANSCAN JTC 2011: Critical aspects of the startup procedures of an International Academic Clinical trial (ET-FES), funded by the European Community (EC) and coordinated by an Italian Institution 102
A case series of low dose bevacizumab and chemotherapy in heavily pretreated patients with epithelial ovarian cancer 101
Oncolytic virotherapy: new weapon for breast cancer treatment 101
Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current Therapeutic Scenarios of Breast Cancer 100
Gestione di nausea e vomito nel paziente oncologico. Utilizzo di cerotti transdermici contenenti granisetron in paziente affetto da neoplasia del distretto cervico-cefalico 99
Age influence on some aspects of cardiovascular adaptation to hypertension 98
Stereotactic ablative radiotherapy for oligometastatic prostate cancer 97
A dose-finding study of epirubicin in combination with paclitaxel in the treatment of advanced breast cancer 96
Dual block with lapatinib and trastuzumab versus single agent trastuzumab combined with chemotherapy as neoadjuvant treatment of HER2-positive breast cancer: a meta-analysis of randomized trials 95
Precision Medicine Approaches with Metabolomics and Artificial Intelligence 94
Association of Biomarkers with Serious Cardiac Adverse Events during Abiraterone Acetate Treatment in Castration Resistant Prostate Cancer 92
Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer 91
Phase II Study of Dehydroepiandrosterone in Androgen Receptor-Positive Metastatic Breast Cancer. 91
Previous immune checkpoint inhibitor therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer: Results of a propensity-matched analysis of the OnCovid registry 89
Paclitaxel combinations as front-line and salvage chemotherapy regimens in advanced breast cancer 89
Anthracyclines-paclitaxel combinations in the treatment of breast cancer 88
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study 88
Comparative efficacy of novel combination strategies for unresectable hepatocellular carcinoma: A network metanalysis of phase III trials 86
Delivering adjuvant and neoadjuvant treatments in the early stages of hepatocellular carcinoma 86
Early Assessment by PET with FDG of Response to First-Line Chemotherapy of Metastatic Breast Cancer 85
Implications of metabolism-driven myeloid dysfunctions in cancer therapy 85
SARS-CoV-2 re-infection in a cancer patient with a defective neutralizing humoral response 85
Cardiotoxicity of epirubicin/paclitaxel-containing regimens: Role of cardiac risk factors 84
Survival of metastatic breast carcinoma patients over a 20-year period - A retrospective analysis based on individual patient data from six consecutive studies 84
Dual Effect of Metformin on Breast Cancer Proliferation in a Randomized Presurgical Trial 84
Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial 84
Three-dimensional laser scanning as a reliable and reproducible diagnostic tool in breast cancer related lymphedema rehabilitation: a proof-of-principle study 84
The gemcitabine/epirubicin/paclitaxel trials in advanced breast cancer 83
Clinical activity and cardiac tolerability of non-pegylated liposomal doxorubicin in breast cancer: a synthetic review 83
Dose-finding study and pharmacokinetics of epirubicin and paclitaxel over 3 hours: A regimen with high activity and low cardiotoxicity in advanced breast cancer 83
Breast cancer "tailored follow-up" in Italian oncology units: a web-based survey 83
The science behind vitamins and natural compounds for breast cancer prevention. Getting the most prevention out of it. 82
Cardiotossicità da antracicline 82
New Understanding of the Role of Anthracyclines in Early-Stage Breast Cancer: Patient Selection Considerations 81
Paclitaxel plus epirubicin in advanced breast cancer 81
Extending the duration of first-line chemotherapy in metastatic breast cancer: A perspective review 80
Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma 79
New combinations with epirubicin in advanced breast cancer 79
Primary chemotherapy with gemcitabine, epirubicin and taxol (GET) in operable breast cancer: a phase II study 79
Bevacizumab and breast cancer: A meta-analysis of first-line phase III studies and a critical reappraisal of available evidence 79
Phenotypic Characteristics of the Tumour Microenvironment in Primary and Secondary Hepatocellular Carcinoma 79
Apalutamide, darolutamide and enzalutamide for nonmetastatic castration-resistant prostate cancer (nmCRPC) 79
Untargeted lipidomics reveal association of elevated plasma C18 ceramide levels with reduced survival in metastatic castration-resistant prostate cancer patients 78
The quality of life issue in metastatic breast cancer 78
Myelopoiesis, metabolism and therapy: a crucial crossroads in cancer progression. 78
Breast Cancer Diet "BCD": A Review of Healthy Dietary Patterns to Prevent Breast Cancer Recurrence and Reduce Mortality 77
Novel immunotherapy combinations in clinical trials for hepatocellular carcinoma: will they shape the future treatment landscape? 74
Lack of benefit of maintenance paclitaxel in first-line chemotherapy in metastatic breast cancer 74
Duration of Chemotherapy for Metastatic Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Clinical Trials 73
Body mass index and prognosis of metastatic breast cancer patients receiving first-line chemotherapy 73
Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review 72
Paclitaxel and vinorelbine in anthracycline-pretreated breast cancer: A phase II study 72
Multicentric phase II trial of gemcitabine plus epirubicin plus paclitaxel as first-line chemotherapy in metastatic breast cancer 72
Rapid intravenous premedication with dexamethasone prevents hypersensitivity reactions to paclitaxel 71
Microinjections of alpha 1- and alpha 2-noradrenergic substances in the cerebellar vermis of decerebrate cats affect the gain of the vestibulospinal reflexes 71
Totale 10.407
Salva come PNG Salva come JPEG
Categoria #
all - tutte 76.517
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.517
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021132 0 0 0 0 0 0 0 0 0 0 0 132
2021/2022892 65 23 84 107 29 33 60 32 92 60 135 172
2022/20231.814 162 69 132 18 69 138 54 75 992 21 45 39
2023/2024756 90 29 53 26 128 17 126 17 19 13 52 186
2024/20252.045 28 26 140 31 53 138 255 214 607 193 76 284
2025/20266.964 294 238 458 895 623 503 943 1.091 489 654 506 270
Totale 14.950